RSI spoločnosti Apellis Pharmaceuticals Inc
Aká je hodnota metriky RSI spoločnosti Apellis Pharmaceuticals Inc?
Hodnota metriky RSI spoločnosti Apellis Pharmaceuticals Inc je 50.25
Aká je definícia metriky RSI?
Index relatívnej sily (Relative strength index - RSI 14) je technický ukazovateľ, ktorý sa radí medzi momentum indikátory a meria rýchlosť a zmenu ceny. Jeho hodnota sa pohybuje medzi 0 a 100 a používa sa na charakterizovanie prekupovaného a prepredaného stavu.
It is used to identify overbought or oversold conditions in the trading of an asset. It oscillates between 0 and 100 and a stock is considered overbought when the RSI is above 70 and oversold when below 30. The relative strength index (RSI) is typically used on a 14-day timeframe and is calculated according to the formula 100 - [ 100 / (1 + RS)] where RS is the ratio of average gain to average loss. In the calculation of average gain and loss for a certain period, taking the prior value plus the current value is a smoothing technique similar to that used in calculating an exponential moving average. This also means that RSI values become more accurate as the calculation period extends.
Sudden large price movements can create false buy or sell signals in the RSI. The RSI is often used in conjunction with trend lines, as trend line support or resistance often coincides with support or resistance levels in the RSI reading. Watching for divergence between price and the RSI indicator is another means of refining its application. Divergence occurs when a security makes a new high or low in price but the RSI does not make a corresponding new high or low value. Bearish divergence, when price makes a new high but the RSI does not is taken as a sell signal. Bullish divergence that is interpreted as a buy signal occurs when price makes a new low, but the RSI value does not.
RSI spoločností v sektore Health Care sektor na NASDAQ v porovnaní so spoločnosťou Apellis Pharmaceuticals Inc
Čomu sa venuje spoločnosť Apellis Pharmaceuticals Inc?
apellis pharmaceuticals is an early stage biotechnology company applying immunotherapy to auto-immune diseases, with an initial emphasis on diseases of the lungs such as asthma and chronic obstructive pulmonary disease (copd), diseases of the retina such as age-related macular degeneration (amd), and rare hematological diseases such as paroxysmal nocturnal hemoglobinuria (pnh). apellis believes that targeting a key element in the immune system called the complement system can have profound disease modifying benefits. we call this approach complement immunotherapy.
Firmy s metrikou rsi podobnou spoločnosti Apellis Pharmaceuticals Inc
- Hodnota metriky RSI spoločnosti American je 50.23
- Hodnota metriky RSI spoločnosti iShares ETF (CH) - iShares SMIM (CH) je 50.23
- Hodnota metriky RSI spoločnosti GraniteShares 3x Short Barclays Daily ETC je 50.24
- Hodnota metriky RSI spoločnosti Kratos Defense & Security Solutions Inc je 50.24
- Hodnota metriky RSI spoločnosti Alnylam Pharmaceuticals je 50.24
- Hodnota metriky RSI spoločnosti Visio Nerf je 50.24
- Hodnota metriky RSI spoločnosti Apellis Pharmaceuticals Inc je 50.25
- Hodnota metriky RSI spoločnosti Principal Inc je 50.26
- Hodnota metriky RSI spoločnosti Eminent Gold je 50.26
- Hodnota metriky RSI spoločnosti Eagle Bancorp Inc (MD) je 50.26
- Hodnota metriky RSI spoločnosti Hang Lung je 50.27
- Hodnota metriky RSI spoločnosti Ams Ag je 50.27
- Hodnota metriky RSI spoločnosti Learning Technologies Plc je 50.28